webinar register page

Webinar banner
Using Speech Biomarkers in Dementia Clinical Research
The expanding use of speech biomarkers as drug development tools has allowed researchers to better understand the symptoms and disease progression of patients with dementia. The use of acoustic, linguistic, and content analysis can assist with diagnosis and may discriminate between forms of dementia. At this year's Alzheimer’s Association International Conference annual meeting Winterlight presented new data on how speech biomarkers can be used in clinical research. In this webinar, Jessica Robin, PhD, Director of Clinical Research at Winterlight Labs, and Jed Meltzer, PhD, Neurorehabilitation Scientist at Rotman Research Institute, will discuss:

- How to use open-ended speech tasks, such as clinical interviews, to determine cognition and function.
- How to measure executive function using objective, speech-based biomarkers.
- How to discriminate between Alzheimer’s Disease, Frontotemporal dementia, and Parkinson’s dementia using speech biomarkers.
- Updates on how voice and speech biomarkers are being used in intervention studies of new treatments for dementia.

Sep 22, 2021 12:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information
Loading

Speakers

Jessica Robin, PhD
Director of Clinical Research @Winterlight Labs
Dr. Robin leads Winterlight Labs' clinical research program, and her research focuses on speech patterns in neurodegenerative disease. Dr. Robin completed her PhD in cognitive neuroscience at the University of Toronto and her postdoc at the Rotman Research Institute, funded by the Alzheimer's Society of Canada.
Jed Meltzer, PhD
Canada Research Chair in Interventional Cognitive Neuroscience @Rotman Research Institute
Dr. Meltzer is a cognitive neuroscientist specializing in language, with research interests both in the basic science of language processing from a neurobiological perspective, and in applications to the diagnosis and treatment of acquired neurological disorders such as stroke and dementia.
Nicola Johnson
Senior Manager, Business Development @Winterlight Labs
Nicola leads business development at Winterlight Labs and combines past experiences in both digital health and pharma to create successful partnerships with life sciences clients with an emphasis on accelerating growth and delivering long-lasting value.